Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:609-616

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ono, Y.
Right arrow Articles by Frohlich, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ono, Y.
Right arrow Articles by Frohlich, E. D.
Related Collections
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Animal models of human disease
Right arrow Apoptosis
Right arrow Hypertension - basic studies

(Hypertension. 1999;34:609-616.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Apoptosis, Coronary Arterial Remodeling, and Myocardial Infarction After Nitric Oxide Inhibition in SHR

Yuko Ono; Hidehiko Ono; Hiroaki Matsuoka; Takahiro Fujimori; Edward D. Frohlich

From the Hypertension Research Laboratory, Alton Ochsner Medical Foundation (Y.O., H.O., E.D.F), New Orleans, La; and the Division of Hypertension and Cardiorenal Disease (H.M.), Departments of Medicine and Pathology (T.F.), Dokkyo University School of Medicine, Tochigi, Japan.

Abstract—This study was designed to investigate the relationship between apoptosis (programmed cell death) and coronary arterial remodeling in spontaneously hypertensive rats (SHR) following prolonged nitric oxide synthesis inhibition. In addition, we evaluated whether the development of coronary arterial smooth muscular cell apoptosis was related to hemodynamics or to vascular hypertrophy. Three groups of 20-week-old male SHR were investigated: controls, and two groups that received two doses of NG-nitro-L arginine (L-NAME, 50 mg/L and 80 mg/L) each for 3 weeks. Mean arterial pressure and total peripheral resistance index increased whereas cardiac index diminished with L-NAME. Pathohistological study demonstrated increased pericardiac fibrosis and coronary arterial injury score in the L-NAME group in a dose-dependent manner. The high dose of L-NAME (Group 3) produced myocardial infarction in 78% of the rats. The wall:lumen ratio of epicardial coronary arteries was greater in L-NAME treated SHR (0.23±0.02 versus 0.16±0.02; P<0.05) and was associated with markedly increased apoptosis (15.3±6 versus 1.9±1; P<0.05) without smooth muscle cell proliferation (PCNA positive cells). Apoptosis occurred predominantly in hypertrophic coronary arterial smooth muscular cells; myocardial infarction and ventricular fibrosis were exacerbated by impaired hemodynamics induced by L-NAME. These data suggest that coronary endothelial dysfunction and myocardial ischemic disease induced by L-NAME were responsible for apoptosis of coronary arterial smooth muscle cells, myocardial fibrosis, and infarction, all pathological findings that are consistent with what may be found in clinical hypertensive heart disease.


Key Words: apoptosis • nitric oxide • L-NAME • microvascular remodeling • myocardial infarction • ventricular fibrosis • myocardial hemodynamics • spontaneously hypertensive rat




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. F. Benter, M. H. M. Yousif, J. T. Anim, C. Cojocel, and D. I. Diz
Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H684 - H691.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Ono, Y. Ono, A. Takanohashi, H. Matsuoka, and E. D. Frohlich
Apoptosis and Glomerular Injury After Prolonged Nitric Oxide Synthase Inhibition in Spontaneously Hypertensive Rats
Hypertension, December 1, 2001; 38(6): 1300 - 1306.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
D. Casellas, A. Herizi, A. Artuso, A. Mimran, and B. Jover
Candesartan prevents L-NAME-induced cardio-renal injury in spontaneously hypertensive rats beyond hypotensive effects
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S84 - S90.
[Abstract] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. R. Quinlan, D. Li, V. E. Laubach, E. G. Shesely, N. Zhou, and R. A. Johns
eNOS-deficient mice show reduced pulmonary vascular proliferation and remodeling to chronic hypoxia
Am J Physiol Lung Cell Mol Physiol, October 1, 2000; 279(4): L641 - L650.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. J. Cox, H. S. Sood, M. J. Hunt, D. Chandler, J. R. Henegar, G. M. Aru, and S. C. Tyagi
Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats
Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1197 - H1205.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Yu, S. Tian, L. Metheny-Barlow, L.-J. Chew, A. J. Hayes, H. Pan, G.-L. Yu, and L.-Y. Li
Modulation of Endothelial Cell Growth Arrest and Apoptosis by Vascular Endothelial Growth Inhibitor
Circ. Res., December 7, 2001; 89(12): 1161 - 1167.
[Abstract] [Full Text] [PDF]